文献速递糖尿病

香港糖尿病生物样本库分析:连接2型糖尿病中糖尿病肾脏病与 incident 心血管疾病的循环代谢组标志物

Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.
PubMed 文献 · Diabetologia · 2024-02-27

研究基于香港糖尿病生物样本库前瞻性队列1991例2型糖尿病患者基线血清,用核磁共振波谱定量170种代谢物,中位随访5.2年。发现糖尿病肾脏病相关代谢物谱与 incident 心血管疾病相关,由年龄、性别和三种代谢物(白蛋白、大HDL甘油三酯、小LDL磷脂)构成的模型预测效能与传统危险因素相当,加入三种代谢物后C统计量从0.762升至0.797(p=0.014),并在中国和荷兰独立队列中验证。

要点

  • 在FDR<0.05下,156种代谢物与糖尿病肾脏病相关,包括载脂蛋白B脂蛋白、HDL、脂肪酸、苯丙氨酸、酪氨酸、白蛋白和糖蛋白乙酰基。
  • 随访5.2年,75种代谢物与 incident 心血管疾病相关(FDR<0.05)。
  • 三种代谢物评分(白蛋白、大HDL甘油三酯、小LDL磷脂)联合年龄、性别预测心血管疾病,C统计量0.765,与传统危险因素0.762相当(p=0.893)。

核心结论

  • 糖尿病肾脏病中改变的代谢组学特征与 incident 心血管疾病相关,并改善心血管疾病风险分层。

研究设计与样本

  • 前瞻性队列研究,来自香港糖尿病生物样本库的2型糖尿病患者,基线血清N=1991,用核磁共振波谱定量170种代谢物,中位随访5.2年。

主要发现

  • 在FDR<0.05下,156种代谢物与糖尿病肾脏病相关(151种与慢性肾脏病相关,128种与严重增加的蛋白尿相关)。
  • 在FDR<0.05下,75种代谢物与 incident 心血管疾病相关。
  • 由年龄、性别和三种代谢物(白蛋白、大HDL甘油三酯、小LDL磷脂)构成的模型C统计量0.765,传统危险因素模型0.762,两者比较p=0.893。
  • 加入三种代谢物后C统计量从0.762升至0.797(p=0.014),并改善区分度和重分类。
  • 三种代谢物评分在中国和荷兰独立队列中得到验证。

关键数值与推荐

  • 慢性肾脏病定义为eGFR<60 ml/min per 1.73 m2。
  • 严重增加的蛋白尿为糖尿病肾脏病的定义成分之一。
  • 代谢物与结局的关联在FDR<0.05下判定统计学显著。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this study was to describe the metabolome in diabetic kidney disease (DKD) and its association with incident CVD in type 2 diabetes, and identify prognostic biomarkers. METHODS: From a prospective cohort of individuals with type 2 diabetes, baseline sera (N=1991) were quantified for 170 metabolites using NMR spectroscopy with median 5.2 years of follow-up. Associations of chronic kidney disease (CKD, eGFR<60 ml/min per 1.73 m2) or severely increased albuminuria with each metabolite were examined using linear regression, adjusted for confounders and multiplicity. Associations between DKD (CKD or severely increased albuminuria)-related metabolites and incident CVD were examined using Cox regressions. Metabolomic biomarkers were identified and assessed for CVD prediction and replicated in two independent cohorts. RESULTS: At false discovery rate (FDR)<0.05, 156 metabolites were associated with DKD (151 for CKD and 128 for severely increased albuminuria), including apolipoprotein B-containing lipoproteins, HDL, fatty acids, phenylalanine, tyrosine, albumin and glycoprotein acetyls. Over 5.2 years of follow-up, 75 metabolites were associated with incident CVD at FDR<0.05. A model comprising age, sex and three metabolites (albumin, triglycerides in large HDL and phospholipids in small LDL) performed comparably to conventional risk factors (C statistic 0.765 vs 0.762, p=0.893) and adding the three metabolites further improved CVD prediction (C statistic from 0.762 to 0.797, p=0.014) and improved discrimination and reclassification. The 3-metabolite score was validated in independent Chinese and Dutch cohorts. CONCLUSIONS/INTERPRETATION: Altered metabolomic signatures in DKD are associated with incident CVD and improve CVD risk stratification.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Jin Q, Lau ESH, Luk AO, et al. Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank. Diabetologia. 2024. PMID: 38413437. doi:10.1007/s00125-024-06108-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。